377 related articles for article (PubMed ID: 19133915)
1. The metabolic syndrome and schizophrenia.
Meyer JM; Stahl SM
Acta Psychiatr Scand; 2009 Jan; 119(1):4-14. PubMed ID: 19133915
[TBL] [Abstract][Full Text] [Related]
2. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
Stahl SM; Mignon L; Meyer JM
Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
[TBL] [Abstract][Full Text] [Related]
3. Medical risk in patients with bipolar disorder and schizophrenia.
Newcomer JW
J Clin Psychiatry; 2006; 67 Suppl 9():25-30; discussion 36-42. PubMed ID: 16965186
[TBL] [Abstract][Full Text] [Related]
4. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.
Newcomer JW
J Clin Psychiatry; 2007; 68 Suppl 1():20-7. PubMed ID: 17286524
[TBL] [Abstract][Full Text] [Related]
5. Diabetes and schizophrenia 2005: are we any closer to understanding the link?
Holt RI; Bushe C; Citrome L
J Psychopharmacol; 2005 Nov; 19(6 Suppl):56-65. PubMed ID: 16280338
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
Casey DE; Haupt DW; Newcomer JW; Henderson DC; Sernyak MJ; Davidson M; Lindenmayer JP; Manoukian SV; Banerji MA; Lebovitz HE; Hennekens CH
J Clin Psychiatry; 2004; 65 Suppl 7():4-18; quiz 19-20. PubMed ID: 15151456
[No Abstract] [Full Text] [Related]
7. Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia.
Brunero S; Lamont S; Fairbrother G
Arch Psychiatr Nurs; 2009 Jun; 23(3):261-8. PubMed ID: 19446781
[TBL] [Abstract][Full Text] [Related]
8. Clozapine and cardiometabolic health in chronic schizophrenia: correlations and consequences in a clinical context.
Malhi G; Adams D; Plain J; Coulston C; Herman M; Walter G
Australas Psychiatry; 2010 Feb; 18(1):32-41. PubMed ID: 20039791
[TBL] [Abstract][Full Text] [Related]
9. Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies.
Bou Khalil R
Clin Neuropharmacol; 2012; 35(3):141-7. PubMed ID: 22592510
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome and cardiovascular disease.
Citrome L
J Psychopharmacol; 2005 Nov; 19(6 Suppl):84-93. PubMed ID: 16280341
[TBL] [Abstract][Full Text] [Related]
11. Can metformin or rosiglitazone reduce metabolic side effects associated with atypical antipsychotics?
Housel AK; Waterbury N; Argo TR
Issues Ment Health Nurs; 2009 Dec; 30(12):803-5. PubMed ID: 19916816
[No Abstract] [Full Text] [Related]
12. Biological perspectives. Metabolic syndrome: schizophrenia and atypical antipsychotics.
Keltner NL
Perspect Psychiatr Care; 2006 Aug; 42(3):204-7. PubMed ID: 16916424
[No Abstract] [Full Text] [Related]
13. Metabolic syndrome and mental illness.
Newcomer JW
Am J Manag Care; 2007 Nov; 13(7 Suppl):S170-7. PubMed ID: 18041878
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic medications: metabolic and cardiovascular risk.
Newcomer JW
J Clin Psychiatry; 2007; 68 Suppl 4():8-13. PubMed ID: 17539694
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia.
Said MA; Sulaiman AH; Habil MH; Das S; Bakar AK; Yusoff RM; Loo TH; Bakar SA
Singapore Med J; 2012 Dec; 53(12):801-7. PubMed ID: 23268153
[TBL] [Abstract][Full Text] [Related]
16. Strategies for the long-term treatment of schizophrenia: real-world lessons from the CATIE trial.
Meyer JM
J Clin Psychiatry; 2007; 68 Suppl 1():28-33. PubMed ID: 17286525
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome and associated cardiovascular risk factors in the treatment of persons with human immunodeficiency virus and severe mental illness.
Vergara-Rodriguez P; Vibhakar S; Watts J
Pharmacol Ther; 2009 Dec; 124(3):269-78. PubMed ID: 19647020
[TBL] [Abstract][Full Text] [Related]
18. The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia.
Mulder H; Franke B; van der-Beek van der AA; Arends J; Wilmink FW; Scheffer H; Egberts AC
J Clin Psychopharmacol; 2007 Aug; 27(4):338-43. PubMed ID: 17632216
[TBL] [Abstract][Full Text] [Related]
19. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
Rzewuska M
Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome: epidemiology and consequences.
Sacks FM
J Clin Psychiatry; 2004; 65 Suppl 18():3-12. PubMed ID: 15600380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]